Information on IMD45
Basic details
Name: Immunodeficiency 45 | Acronym: IMD45
Alt. names:
Gene: IFNAR2 | MOI: Autosomal recessive | Mechanism of action: Loss of Function
No. of cases in DB: 0 | First reported in: 2020
Last updated on: 2023-07-13 12:23:38 by Andrés Caballero-Oteyza
Description
Condition first described by Duncan et al. in 2020 (PMID:35442417) in 5 unrelated children from Greenland, Canada, and Alaska, who all carried the same homozygous p.Ser53Pro missense variant and who were suspected to have a common Inuit ancestor, since the minor allele frequency of the variant in Inuits is 0.034. The patients presented with with life-threatening respiratory infections inclduing COVID-19 or influenza and with severe adverse reactions (e.g., meningoencephalitis and hemophagocytic lymphohistiocytosis) to live attenuated viral vaccination. In vitro studies showed impaired responses to alpha-interferon, impaired type I interferon response after stimulation, and increased vulnerability to multiple viruses.
Management
Description of management option has not been reviewed yet.
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
0 reported cases added to GenIA
SubjectID | Sex | Fam.ID | AD | AFM | Validity | Country | Population | Reference & Pub.code |
---|
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).
Summary of clinical findings
[Considering only Definitive and Possible cases]
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
Treatment ⓘ | Responses & clinical indications |
---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.